N-Power Medicine
N-Power Medicine is seeking a highly experienced Epidemiology Director to lead observational research studies and contribute to the development of data platforms and real-world evidence generation. The role involves collaboration across various teams to support innovative approaches in clinical trials and external controls, working remotely within the United States.
Headquarters
Redwood City, California, United States
Company Size
51-200 employees
Founded
2021
N-Power Medicine operates an always-on clinical research system embedded in community oncology practices, turning routine care into research to accelerate and de-risk oncology drug development. Its offerings include the Kaleido Registry, prospective external control cohorts, and a Community Trial Accelerator that enable robust comparator groups, comprehensive pre‑screening, and signal-based site activation to improve enrollment and trial diversity. A human-in-the-loop AI platform, embedded virtual staff, and point-of-care EHR integration reduce clinician burden and surface eligible patients across a growing network of community oncologists. The company emphasizes security and quality (HIPAA, ISO 27001, ISO 9001) to deliver faster, more reliable development decisions for sponsors.
N-Power Medicine and AdventHealth Collaborate to Expand Access to Cancer Care and Research
Jan 8, 2026
N-Power Medicine Launches Industry’s First Prospective External Control Arm Platform to Dramatically Accelerate Oncology Drug Development and Reduce Reliance on Randomization
Aug 19, 2025
N-Power links up with Syapse to add oncologists to clinical research network
Jan 14, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for N-Power Medicine.
N-Power Medicine partners with MSD to expand access to oncology clinical trials
Jul 2, 2024
Senior Manager, Epidemiology
Regeneron Pharmaceuticals
Director Clinical Intelligence Evidence %E2%80%93 Cardiovascular Renal And Metabolism Cambridge Cambridgeshire United Kingdom
AstraZeneca
Senior Director, Epidemiology
AstraZeneca
Senior Principal Biostatistician (Epidemiology)
Edwards Lifesciences
Associate Director, Epidemiology
GSK plc
Associate Director, Epidemiology (HPV)
GSK plc